SKIN & AESTHETICS
Two Research Peptides, One Skin Question
A digest of the published science on GHK-Cu and the GLOW multi-peptide blend — what each was actually studied for, in which models, and how far the evidence really reaches.
GHK-Cu
The lead peptide on this desk — a copper-binding tripeptide whose collagen-stimulating effects are the best-documented human signal in the skin-peptide literature.
Read the research →
GLOW (research blend)
A co-formulated stack of GHK-Cu, BPC-157, and TB-500 with a skin-and-repair rationale — and a candid record of what no study has yet tested about them together.
Read the research →The short version
Peptide Bounce Balm is a reading desk, not a store. It collects what the published research literature actually says about two peptides that keep appearing in conversations about skin remodeling, hair, and tissue aesthetics: GHK-Cu and the GLOW blend. A peptide is a short chain of amino acids — the same building blocks as proteins, just far smaller. These two have been studied because they appear to engage parts of the body's matrix-repair and regeneration machinery: building collagen and elastin, growing new blood vessels, and helping cells migrate into damaged tissue.
This desk does one job: it tells you, in plain language and with citations, what each peptide was tested on, in which species (and at what scale), and how far that evidence really reaches. Most of it is preclinical or limited to small topical trials. Neither compound is an approved medicine. We do not sell anything, we do not give medical advice, and we never list a human dose.
What are research peptides?
Proteins in the body — collagen in the dermis, a signaling hormone, a structural scaffold — are long chains of amino acids folded into a shape. A peptide is a much shorter chain of those same amino acids, sometimes only three or four links long. Because they are small and precise, peptides can act like molecular keys that fit particular receptors, switching specific processes on or off.
A research peptide is one that has been synthesized and studied in the laboratory — in cell cultures, in animals, occasionally in early human pilots — but has not been approved by a regulator as a medicine for that purpose. Research suppliers describe these compounds as being for laboratory use only, and that framing matters: it means dosing, long-term safety, and real-world effectiveness in people are usually unestablished. When this desk reports a number, it reports it the way the study did — for example, studied at picomolar concentrations in human fibroblast cultures — never as a recommendation.
How these two fit into skin and aesthetics research
The two peptides on this desk approach skin repair from different angles, and that contrast is precisely why they sit together.
- GHK-Cu is the lead. It is a three-amino-acid peptide chelated to a copper ion, derived from a motif inside type I collagen, and its claim to the aesthetic-peptide canon rests on a documented ability to signal dermal fibroblasts to synthesize collagen, elastin, glycosaminoglycans and decorin [4][6]. Plasma GHK falls with age, topical copper-tripeptide formulations are legal cosmetic ingredients, and one 45-patient RCT of a GHK-containing topical produced statistically significant hair-count improvements versus placebo [3].
- GLOW is a supplier- and clinic-formulated blend of GHK-Cu, BPC-157, and TB-500 — three peptides whose research mechanisms are complementary on paper (matrix building, angiogenesis, cell migration) but have never been tested as a combination in a controlled study [8]. Its skin reputation is borrowed mostly from GHK-Cu's constituent record, layered with a tissue-repair rationale from the other two components.
Together they sketch two vantage points on the same aesthetic question: a single well-characterized molecule with decades of topical and cell-biology work behind it, and a multi-component blend whose combination thesis remains an inference rather than a finding. Use the card links above to read each one, or compare these peptides side by side.
A note on how this desk reads the literature
Peptide Bounce Balm is a cross-referenced literature digest. Each page summarizes the peer-reviewed studies for that compound, cites them by number, and links to a single shared references page that aggregates every source. Where evidence is thin, preclinical, or concentrated in a single research group, we say so plainly — that candor about limits is part of the record, not a footnote to it. The aim is an accurate map of what is known: where the science is solid, where it is early-stage, and where enthusiastic claims have outrun the data.